VolitionRx Ltd amended its underwriting agreement on November 7, 2025, allowing the underwriter to purchase a combination of shares and warrants from a recent public offering, which includes 11,550,000 shares at $0.52 each, along with additional options to buy 1,732,500 shares and warrants. This amendment followed the original agreement dated October 10, 2025, which had typographical errors corrected in this report.